GERRESHEIMER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.32 EUR | -0.08% |
|
+1.32% | +5.46% |
| May. 16 | GERRESHEIMER AG : UBS reiterates its Buy rating | ZD |
| May. 15 | Schott Pharma falls sharply - 'High dependence on end markets' | DP |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.13B 2.32B | Sales 2025 * | 2.39B 2.6B | Capitalization | 3.43B 3.74B |
|---|---|---|---|---|---|
| Net income 2024 * | 142M 155M | Net income 2025 * | 194M 211M | EV / Sales 2024 * | 2.08 x |
| Net Debt 2024 * | 993M 1.08B | Net Debt 2025 * | 968M 1.05B | EV / Sales 2025 * | 1.84 x |
| P/E ratio 2024 * |
24
x | P/E ratio 2025 * |
17.6
x | Employees | 11,947 |
| Yield 2024 * |
1.33% | Yield 2025 * |
1.61% | Free-Float | 100% |
More Fundamentals
* Assessed data
More news
Latest transcript on Gerresheimer AG
More recommendations
More press releases
More news
| 1 day | +0.20% | ||
| 1 week | -1.00% | ||
| Current month | -1.58% | ||
| 1 month | +0.51% | ||
| 3 months | +9.11% | ||
| 6 months | +18.19% | ||
| Current year | +5.35% |
1 week
96.75
103.90
1 month
96.75104.50
Current year
84.80111.20
1 year
81.35122.90
3 years
46.66122.90
5 years
46.66122.90
10 years
41.04122.90
| Managers | Title | Age | Since |
|---|---|---|---|
Dietmar Siemssen
CEO | Chief Executive Officer | 60 | 18-10-31 |
Bernd Metzner
DFI | Director of Finance/CFO | 53 | 19-05-14 |
Guido Pickert
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Axel Herberg
CHM | Chairman | 66 | 13-12-31 |
| Director/Board Member | 67 | 12-04-25 | |
| Director/Board Member | 69 | 06-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.62% | 17 M€ | -.--% | - | |
| 2.97% | 202 M€ | -.--% | ||
| 0.25% | 18 M€ | +7.68% | ||
| 0.23% | 79 M€ | -.--% | ||
| 0.07% | 746 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 99.5 | +0.10% | 1 042 |
| 24-05-17 | 99.4 | -2.64% | 74,824 |
| 24-05-16 | 102.1 | +0.99% | 80,994 |
| 24-05-15 | 101.1 | +0.60% | 164,716 |
| 24-05-14 | 100.5 | +2.34% | 119,971 |
Delayed Quote Xetra, May 17, 2024 at 11:35 am EDT
More quotes
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Calendar
2024-05-20
- Global Drug Delivery & Formulation Summit
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
99.4
EUR
Average target price
133.8
EUR
Spread / Average Target
+34.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.35% | 3.73B | |
| -5.43% | 181B | |
| +4.30% | 114B | |
| -3.09% | 68.29B | |
| +5.86% | 52.24B | |
| +8.15% | 44.3B | |
| +6.67% | 42.73B | |
| +25.54% | 32.52B | |
| +20.03% | 26.02B | |
| +1.00% | 25.91B |
- Stock Market
- Equities
- GXI Stock
